SUBSCRIBE
SUBSCRIBE
News   Policy

Cornerstone Therapeutics Inc. Gets U.S. FDA Warning

November 23, 2009 | 
1 min read
Bookmark and Share

Reuters -- U.S. regulators warned Cornerstone Therapeutics that the company has distributed drugs without approved applications, a letter released on Friday said.
Regulatory
Food and Drug Administration (FDA) Chiesi, USA
MORE ON THIS TOPIC
Insights
From fragile skin to living medicine: Lessons from RDEB
June 18, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Stand out from the crowd and different creative idea concepts , Longest light ladder glowing and aiming high to goal target among other short ladders on green background with shadows . 3D rendering.
Approvals
GSK, Spero’s oral antibiotic wins first FDA nod for complicated UTI
June 18, 2026
 · 
2 min read
 · 
Tristan Manalac
The white plane flies against the blue sky, leaving a white trail. Vector illustration
Huntington’s disease
UniQure plans Q3 submission for Huntington’s gene therapy after FDA reverses course—again
June 17, 2026
 · 
4 min read
 · 
Heather McKenzie
Podcast
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
June 17, 2026
 · 
2 min read
 · 
Jef Akst